20 Slash 20 Inc., the innovator behind The Eye Drink, is being featured in coverage of the Disruptive Growth & Life Sciences Conference hosted by Moody Capital Solutions Inc. The company is presenting its flagship product, The Eye Drink, which is described as the world's first clinically inspired, ready-to-drink functional beverage specifically formulated to minimize ocular issues in today's screen-heavy world.
The Eye Drink is designed for individuals who spend long hours daily staring at computer or cellphone screens, aiming to reduce screen-induced dry eyes and macular damage. It utilizes science-backed nutrients based on AREDS 2 Studies, along with vegan-friendly triglyceride-formed Omega-3, to protect visual performance and improve ocular comfort. This formulation targets a growing concern as digital device usage continues to rise globally.
Through direct-to-consumer sales, professional medical affiliate channels, and natural product retail stores, 20 Slash 20 is modernizing preventive eyecare. The company aims to transform clinical science into a simple, delicious, and enjoyable daily habit, making eye health more accessible to the general public.
The conference, organized by Moody Capital Solutions, an independent investment bank with over 40 years of experience in capital raising, M&A, and advisory services, is focused on disruptive growth and life sciences. Moody Capital is recognized as a market leader in rights offerings and is a member of FINRA/SIPC.
IBN, a multifaceted financial news and publishing company, is providing online investment community coverage of the event. IBN has created a custom-built portal that includes summaries on each participating company, enabling proficient evaluation via one-click access to market research tools and helpful website links. IBN is also using social media and syndicated articles to maximize the visibility of the event.
For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts, and investment newsletters. This year, IBN's syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
The inclusion of 20 Slash 20 at this conference highlights the growing intersection of health and technology, particularly the importance of proactive measures to combat the side effects of prolonged screen use. As remote work and digital entertainment become more prevalent, the demand for products like The Eye Drink may increase, potentially impacting the functional beverage market and preventive healthcare sectors.
Attendees and interested parties can learn more about the conference by visiting Moody Capital's conference page. For more information about 20 Slash 20 and The Eye Drink, visit theeyedrink.com. IBN's coverage of the conference is available at this link.
